Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Depreciation & Amortization (CF): 2010-2025

Historic Depreciation & Amortization (CF) for Prestige Consumer Healthcare (PBH) over the last 16 years, with Mar 2025 value amounting to $30.2 million.

  • Prestige Consumer Healthcare's Depreciation & Amortization (CF) fell 3.35% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.4 million, marking a year-over-year decrease of 6.64%. This contributed to the annual value of $30.2 million for FY2025, which is 1.64% down from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Depreciation & Amortization (CF) of $30.2 million as of FY2025, which was down 1.64% from $30.7 million recorded in FY2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Depreciation & Amortization (CF) peaked at $32.6 million during FY2023, and registered a low of $30.2 million during FY2021.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $30.7 million (2024), whereas its average is $31.2 million.
  • In the last 5 years, Prestige Consumer Healthcare's Depreciation & Amortization (CF) rose by 6.39% in 2022 and then declined by 5.98% in 2024.
  • Yearly analysis of 5 years shows Prestige Consumer Healthcare's Depreciation & Amortization (CF) stood at $30.2 million in 2021, then rose by 6.39% to $32.1 million in 2022, then rose by 1.66% to $32.6 million in 2023, then decreased by 5.98% to $30.7 million in 2024, then dropped by 1.64% to $30.2 million in 2025.